united kingdomen
It’s too early to be too gloomy about stocks

It’s too early to be too gloomy about stocks

07-02-2020 | Monthly outlook
The coronavirus has given the world a financial scare as well as a health shock – but there’s no need to put equities into quarantine.
  • Jeroen Blokland
    Jeroen
    Blokland
    Portfolio Manager

Speed read

  • Coronavirus outbreak hits Chinese and global growth
  • Recovery ability leads three positive factors for equities
  • Multi Asset team does take some risk off the table though

That’s the view of Robeco investor Jeroen Blokland, who says there are still many positives for stocks, despite the outbreak of the deadly virus in China that is now spreading across the world.

“The unexpected and unfortunate coronavirus outbreak is putting pressure on the sustainability of the improvement in global growth momentum,” says Blokland, senior portfolio manager with Robeco’s Multi Asset team, which has reduced its exposure to equities as a precaution.

“The fact that the uptick in momentum had only just started makes it relatively vulnerable to any negative shocks. In addition, the significant amount of uncertainty related to containing the virus as well as its economic impact require an appropriately cautious stance on risky assets.”

“‘Appropriate’, however, does not imply getting too gloomy too early, as other factors remain positive for risky assets, and for equities in particular.”

The coronavirus, which began in Wuhan, has now spread across and outside China. The government has reacted by putting Wuhan into lockdown, severely restricting movement in other Chinese cities and extending the Chinese New Year holiday to stop people traveling.

Now also follow us on Instagram
Now also follow us on Instagram
Follow

Drastic measures

“The measures, which might seem drastic, are likely to increase the odds of containment,” says Blokland. “At the same time, however, they are also likely to impact Chinese growth, and therefore also global growth.”

“From this angle, comparisons to the outbreak of the SARS virus back 2003 are futile. The Chinese share of global GDP has more than tripled since then, and China has become the marginal buyer of virtually every commodity. Its sheer size means other emerging countries in the region will face at least a temporary setback in growth as well.”

“It is the combination of a growth shock in China – by far the most important country in terms of share of global GDP – and the uncertainty of how long and how deep this shock will be that has made us erase our overweight to equities in our Multi Asset fund. However, this does not mean we have become outrightly negative on equities.”

Retail sales rose after the 2003 SARS outbreak and may do so again. Source: Bloomberg.

Reasons to be cheerful

Blokland says there are three reasons to be cheerful about equities. “First, when compared to ‘similar’ events, economic activity that is lost during a viral outbreak is largely recouped once it is contained,” he says. “For example, during the SARS outbreak, Chinese retail sales growth briefly halved before making a strong comeback after the virus was brought under control, making up for most of the sales decline.”

“Other parts of the economy such as construction were hit as well, but they also recovered once the spreading of the virus started to decline. We expect to see a similar pattern this time, and do not forecast a major interruption of global supply chains.”

“Second, the global economy showed numerous signs of improvement prior to the outbreak. One example is the global manufacturing PMI, which rose to 50.4 in January, its highest level since April 2019. The ISM Manufacturing Index is also back above 50, following a much bigger-than-expected rise in January.”

Positive surprises

“The Citi Global Economic Surprise Index has turned positive and risen to its highest level in almost two years. Export growth in very open economies such as South Korea has improved markedly, revealing that the downward pressure from the China-US trade war is abating.”

“And roughly halfway through the US company reporting season for the fourth quarter of 2019, earnings surprises are the strongest they have been in the last three quarters, with sales surprises the most upbeat in the last four quarters.”

“Earnings revisions have improved significantly on the outlook of better global growth. And in emerging markets, they are now higher than in the US, suggesting earnings momentum is broadening.”

Earnings per share of companies in the MSCI World Index are improving. Source: Bloomberg.

Accommodative central banks

Finally, investors should bear highly accommodative central bank policy in mind, Blokland says. “Short-term interest rates remain low or even negative, with central bank balance sheets growing again,” he says. “In addition, central banks have made it very clear that the hurdle to monetary policy tightening is very high.”

“Both the US Federal Reserve and the European Central Bank are ‘rethinking’ their monetary policy, with a very likely outcome that they will allow inflation to overshoot the target to make up for lost inflation in the past. At the same time, their willingness to increase stimulus is high if a negative shock like the coronavirus were to endanger the global economy.”

“The Chinese central bank already injected a massive amount of liquidity once markets reopened after the Chinese New Year. Global liquidity remains enormous, and will grow even larger in the coming quarters.”

Market implications

In all, it’s too early to be too gloomy about equities, he says. “Proportionate cautiousness concerning the coronavirus is warranted; obviously the fact that it originated in China – by far the largest growth engine in the world – is of importance here,” he says.

“We would like to stress, however, that other more constructive forces for equities are also at play. Given the fact that events such as the coronavirus tend to have a temporary rather than a structural impact on growth and earnings, we refrain from becoming outrightly negative on equity markets.”

Subjects related to this article are:
Logo

Disclaimer

Please read this important information before proceeding further. It contains legal and regulatory notices relevant to the information contained on this website.

The information contained in the Website is NOT FOR RETAIL CLIENTS - The information contained in the Website is solely intended for professional investors, defined as investors which (1) qualify as professional clients within the meaning of the Markets in Financial Instruments Directive (MiFID), (2) have requested to be treated as professional clients within the meaning of the MiFID or (3) are authorized to receive such information under any other applicable laws. The value of the investments may fluctuate. Past performance is no guarantee of future results. Investors may not get back the amount originally invested. Neither Robeco Institutional Asset Management B.V. nor any of its affiliates guarantees the performance or the future returns of any investments. If the currency in which the past performance is displayed differs from the currency of the country in which you reside, then you should be aware that due to exchange rate fluctuations the performance shown may increase or decrease if converted into your local currency.

In the UK, Robeco Institutional Asset Management B.V. (“ROBECO”) only markets its funds to institutional clients and professional investors. Private investors seeking information about ROBECO should visit our corporate website www.robeco.com or contact their financial adviser. ROBECO will not be liable for any damages or losses suffered by private investors accessing these areas.

In the UK, ROBECO Funds has marketing approval for the funds listed on this website, all of which are UCITS funds. ROBECO is authorized by the AFM and subject to limited regulation by the Financial Conduct Authority. Details about the extent of our regulation by the Financial Conduct Authority are available from us on request.

Many of the protections provided by the United Kingdom regulatory framework may not apply to investments in ROBECO Funds, including access to the Financial Services Compensation Scheme and the Financial Ombudsman Service. No representation, warranty or undertaking is given as to the accuracy or completeness of the information on this website.

If you are not an institutional client or professional investor you should therefore not proceed. By proceeding please note that we will be treating you as a professional client for regulatory purposes and you agree to be bound by our terms and conditions.

If you do not accept these terms and conditions, as well as the terms of use of the website, please do not continue to use or access any pages on this website.

I Disagree